CTLA4 and neoplasm: In particular, it has been demonstrated that the MPAK pathway may control PD-L1 and CTLA-4 expression [86] but may also impact on the tumor microenvironment (TME), promoting an immunosuppressive stroma through the secretion of cytokines and growth factors [87].